Tylenol Maker Asks US Appeals Court to Reconsider Revived Autism Lawsuits
Межа. Новини України.
The maker of Tylenol has asked a US appeals court to reconsider revived autism lawsuits, which allege that the drug may have contributed to autism spectrum disorder in children. The company is seeking to have the cases dismissed or limited in scope. The litigation has been reactivated after previous rulings were overturned.
All articles from 12 September 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.